204 related articles for article (PubMed ID: 29056657)
21. Genetic polymorphisms in cyclin H gene are associated with oxaliplatin-induced acute peripheral neuropathy in South Indian digestive tract cancer patients.
Palugulla S; Devaraju P; Kayal S; Narayan SK; Mathaiyan J
Cancer Chemother Pharmacol; 2018 Sep; 82(3):421-428. PubMed ID: 29936608
[TBL] [Abstract][Full Text] [Related]
22. Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer.
Lucchetta M; Lonardi S; Bergamo F; Alberti P; Velasco R; Argyriou AA; Briani C; Bruna J; Cazzaniga M; Cortinovis D; Cavaletti G; Kalofonos HP
Cancer Chemother Pharmacol; 2012 Dec; 70(6):899-902. PubMed ID: 23108696
[TBL] [Abstract][Full Text] [Related]
23. Incidence and risk factors for developing chemotherapy-induced neuropathic pain in 500 cancer patients: A file-based observational study.
Argyriou AA; Bruna J; Kalofonou F; Velasco R; Litsardopoulos P; Alemany M; Anastopoulou GG; Kalofonos HP
J Peripher Nerv Syst; 2024 Mar; 29(1):38-46. PubMed ID: 38311337
[TBL] [Abstract][Full Text] [Related]
24. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
[TBL] [Abstract][Full Text] [Related]
25. Impact of oxaliplatin-induced neuropathy: a patient perspective.
Bennett BK; Park SB; Lin CS; Friedlander ML; Kiernan MC; Goldstein D
Support Care Cancer; 2012 Nov; 20(11):2959-67. PubMed ID: 22426503
[TBL] [Abstract][Full Text] [Related]
26. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
27. Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer.
Choi J; Kong K; Mozaffar T; Holcombe RF
Anticancer Drugs; 2006 Jan; 17(1):103-5. PubMed ID: 16317297
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin-safety profile: neurotoxicity.
Grothey A
Semin Oncol; 2003 Aug; 30(4 Suppl 15):5-13. PubMed ID: 14523789
[TBL] [Abstract][Full Text] [Related]
29. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
[TBL] [Abstract][Full Text] [Related]
30. Nerve excitability assessment in chemotherapy-induced neurotoxicity.
Park SB; Lin CS; Kiernan MC
J Vis Exp; 2012 Apr; (62):. PubMed ID: 22565594
[TBL] [Abstract][Full Text] [Related]
31. A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration.
Beijers AJ; Mols F; Vreugdenhil G
Support Care Cancer; 2014 Jul; 22(7):1999-2007. PubMed ID: 24728618
[TBL] [Abstract][Full Text] [Related]
32. Neurotoxicity caused by the treatment with platinum analogues.
Amptoulach S; Tsavaris N
Chemother Res Pract; 2011; 2011():843019. PubMed ID: 22312559
[TBL] [Abstract][Full Text] [Related]
33. Platinum neurotoxicity pharmacogenetics.
McWhinney SR; Goldberg RM; McLeod HL
Mol Cancer Ther; 2009 Jan; 8(1):10-6. PubMed ID: 19139108
[TBL] [Abstract][Full Text] [Related]
34. Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity.
Chiorazzi A; Semperboni S; Marmiroli P
Toxics; 2015 Aug; 3(3):304-321. PubMed ID: 29051466
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Exercise Rehabilitation Program in Relieving Oxaliplatin Induced Peripheral Neurotoxicity.
Gui Q; Li D; Zhuge Y; Xu C
Asian Pac J Cancer Prev; 2021 Mar; 22(3):705-709. PubMed ID: 33773532
[TBL] [Abstract][Full Text] [Related]
36. Role of calcium/ magnesium infusion in oxaliplatin-based chemotherapy for colorectal cancer patients.
Kurniali PC; Luo LG; Weitberg AB
Oncology (Williston Park); 2010 Mar; 24(3):289-92. PubMed ID: 20394142
[TBL] [Abstract][Full Text] [Related]
37. Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.
Zedan AH; Hansen TF; Fex Svenningsen A; Vilholm OJ
Clin Colorectal Cancer; 2014 Jun; 13(2):73-80. PubMed ID: 24365057
[TBL] [Abstract][Full Text] [Related]
38. Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy.
Cavaletti G; Marmiroli P
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32471028
[TBL] [Abstract][Full Text] [Related]
39. Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.
Staff NP; Cavaletti G; Islam B; Lustberg M; Psimaras D; Tamburin S
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2(Suppl 2):S26-S39. PubMed ID: 31647151
[TBL] [Abstract][Full Text] [Related]
40. Platinum-induced neurotoxicity and preventive strategies: past, present, and future.
Avan A; Postma TJ; Ceresa C; Avan A; Cavaletti G; Giovannetti E; Peters GJ
Oncologist; 2015 Apr; 20(4):411-32. PubMed ID: 25765877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
